PubRank

C H Buys

Author PubWeight™ 140.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-activating enzyme. Proc Natl Acad Sci U S A 1993 3.09
2 PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995 2.40
3 Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet 1995 2.33
4 Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosomes Cancer 1998 2.27
5 Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 1999 2.27
6 Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology 2001 1.84
7 MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 1997 1.83
8 Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997 1.81
9 A straightforward approach to isolate DNA sequences with potential linkage to the retinoblastoma locus. Hum Genet 1986 1.80
10 A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A 2000 1.76
11 A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome). Nat Genet 1996 1.65
12 DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996 1.64
13 Persistent failures in gene repair. Nat Biotechnol 2001 1.54
14 Rapid uptake by liver sinusoidal cells of serum albumin modified with retention of its compact conformation. Biochim Biophys Acta 1975 1.45
15 Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease. Hum Mol Genet 1995 1.43
16 Improvement of fragment and primer selection for mutation detection by denaturing gradient gel electrophoresis. Nucleic Acids Res 1998 1.34
17 p53 mutations in human lung tumors. Cancer Res 1992 1.33
18 Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res 1985 1.28
19 Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer 1993 1.25
20 Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosomes Cancer 1997 1.23
21 Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer. Genomics 1996 1.21
22 Localization at a subband level of polymorphic 13q14 DNA probes for diagnosis of hereditary retinoblastoma and Wilson disease. Hum Genet 1987 1.21
23 A loss-of-function mutation in the endothelin-converting enzyme 1 (ECE-1) associated with Hirschsprung disease, cardiac defects, and autonomic dysfunction. Am J Hum Genet 1999 1.21
24 Mutations in Hirschsprung disease: when does a mutation contribute to the phenotype. Eur J Hum Genet 1998 1.18
25 RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat 2000 1.17
26 Report and abstracts of the Fourth International Workshop on Human Chromosome 3 Mapping. Cytogenet Cell Genet 1994 1.15
27 Haplotype identity between individuals who share a CFTR mutation allele "identical by descent": demonstration of the usefulness of the haplotype-sharing concept for gene mapping in real populations. Hum Genet 1996 1.13
28 A role for MLH3 in hereditary nonpolyposis colorectal cancer. Nat Genet 2001 1.11
29 Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. Am J Hum Genet 1996 1.10
30 Mapping of two new markers within the smallest interval harboring the spinal muscular atrophy locus by family and radiation hybrid analysis. Hum Genet 1994 1.10
31 Proteolysis of formaldehyde-treated albumin in Kupffer cells and its inhibition by suramin. J Reticuloendothel Soc 1973 1.09
32 The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy. Cancer Res 2001 1.08
33 Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res 1988 1.08
34 Eight closely linked loci place the Wilson disease locus within 13q14-q21. Am J Hum Genet 1988 1.07
35 Partial 3q duplication syndrome and assignment of D3S5 to 3q25-3q28. Hum Genet 1991 1.06
36 Loss of heterozygosity at the short arm of chromosome 3 in renal-cell cancer correlates with the cytological tumour type. Int J Cancer 1993 1.06
37 Linkage analysis of families with hereditary retinoblastoma: nonpenetrance of mutation, revealed by combined use of markers within and flanking the RB1 gene. Am J Hum Genet 1989 1.06
38 Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J Clin Endocrinol Metab 1996 1.04
39 SMA carrier testing--validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion. Eur J Hum Genet 2000 1.03
40 MEN2A-RET-induced cellular transformation by activation of STAT3. Oncogene 2001 1.03
41 High frequency of TP53 mutations in juvenile pilocytic astrocytomas indicates role of TP53 in the development of these tumors. Brain Pathol 1999 1.02
42 Prenatal diagnosis of cystic fibrosis where single affected child has died. Lancet 1988 1.01
43 Comprehensive and accurate mutation scanning of the CFTR gene by two-dimensional DNA electrophoresis. Hum Mutat 1996 1.00
44 Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin's disease. Blood 1987 0.99
45 Localization of the nucleotide excision repair gene ERCC6 to human chromosome 10q11-q21. Genomics 1992 0.98
46 Improvements in gel composition and electrophoretic conditions for broad-range mutation analysis by denaturing gradient gel electrophoresis. Nucleic Acids Res 1999 0.97
47 The region of common allelic losses in sporadic renal cell carcinoma is bordered by the loci D3S2 and THRB. Genomics 1991 0.96
48 Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart. Eur J Pediatr 2000 0.95
49 A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. Eur J Cancer 1997 0.95
50 A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab 1997 0.95
51 Three novel KCNA1 mutations in episodic ataxia type I families. Hum Genet 1998 0.93
52 RET mutation screening in familial cutaneous lichen amyloidosis and in skin amyloidosis associated with multiple endocrine neoplasia. J Invest Dermatol 1996 0.92
53 The genomic structure of the human UBE1L gene. Gene Expr 1995 0.92
54 Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes Chromosomes Cancer 1990 0.92
55 Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas. Genes Chromosomes Cancer 2000 0.92
56 The physical map of the human RET proto-oncogene. Oncogene 1995 0.92
57 A consanguineous family with Hirschsprung disease, microcephaly, and mental retardation (Goldberg-Shprintzen syndrome). J Med Genet 1999 0.92
58 Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosomes Cancer 1996 0.92
59 Mutation frequency of cystic fibrosis transmembrane regulator is not increased in oligozoospermic male candidates for intracytoplasmic sperm injection. Fertil Steril 1998 0.92
60 Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay. Lab Invest 1994 0.92
61 Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosomes Cancer 1997 0.92
62 The ubiquitin-activating enzyme E1-like protein in lung cancer cell lines. Int J Cancer 2000 0.92
63 Validation of the determination of deltaF508 mutations of the cystic fibrosis gene in over 11 000 mouthwashes. Hum Genet 1996 0.91
64 Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer. Dis Colon Rectum 2001 0.91
65 MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer 2001 0.91
66 Direct molecular analysis of a deletion of 3p in tumors from patients with sporadic renal cell carcinoma. Cancer Genet Cytogenet 1988 0.91
67 Apparent SMA I unlinked to 5q. J Med Genet 1994 0.90
68 An 80 Kb P1 clone from chromosome 3p21.3 suppresses tumor growth in vivo. Oncogene 1996 0.90
69 Linkage and apparent heterogeneity in proximal spinal muscular atrophies. Neuromuscul Disord 1993 0.90
70 Induction of lysosomal storage by suramin. Naunyn Schmiedebergs Arch Pharmacol 1978 0.89
71 Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development. Genes Chromosomes Cancer 1997 0.89
72 New comprehensive denaturing-gradient-gel- electrophoresis assay for KRAS mutation detection applied to paraffin-embedded tumours. Genes Chromosomes Cancer 2000 0.88
73 Complete deficiency of constitutive heterochromatin on a human chromosome 9. Hum Genet 1979 0.88
74 Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site. Hum Mol Genet 1999 0.88
75 A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3. Eur J Hum Genet 1999 0.87
76 Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics 2001 0.87
77 Demonstration of the genuine iso-12p character of the standard marker chromosome of testicular germ cell tumors and identification of further chromosome 12 aberrations by competitive in situ hybridization. Am J Hum Genet 1991 0.87
78 Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma. Cancer Genet Cytogenet 1991 0.87
79 Selective staining of the same set of nucleolar phosphoproteins by silver and Giemsa. A combined biochemical and cytochemical study on staining of NORs. Chromosoma 1984 0.86
80 Substantial reduction of the gastric carcinoma critical region at 6q16.3-q23.1. Genes Chromosomes Cancer 1999 0.86
81 Mutational scanning of large genes by extensive PCR multiplexing and two-dimensional electrophoresis: application to the RB1 gene. Hum Mol Genet 1996 0.86
82 Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines. Pathobiology 1992 0.85
83 Two novel germline mutations of the retinoblastoma gene (RB1) that show incomplete penetrance, one splice site and one missense. J Med Genet 2000 0.85
84 Two small cell lung cancer cell lines established from rigid bronchoscope biopsies. Eur J Cancer Clin Oncol 1988 0.84
85 Improved mutation detection in GC-rich DNA fragments by combined DGGE and CDGE. Nucleic Acids Res 1999 0.84
86 Oncological implications of RET gene mutations in Hirschsprung's disease. Gut 1998 0.83
87 Physical localisation of the chromosomal marker D13S31 places the Wilson disease locus at the junction of bands q14.3 and q21.1 of chromosome 13. Hum Genet 1993 0.83
88 Abundance of protein-bound sulfhydryl and disulfide groups at chromosomal nucleolus organizing regions: a cytochemical study on the selective silver staining of NORs. Chromosoma 1980 0.83
89 Prenatal prediction of spinal muscular atrophy. Experience with linkage studies and consequences of present SMN deletion analysis. Eur J Hum Genet 1996 0.82
90 An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers. Genomics 1999 0.82
91 Exempting homologous pseudogene sequences from polymerase chain reaction amplification allows genomic keratin 14 hotspot mutation analysis. J Invest Dermatol 2000 0.81
92 Localization of DNA probes with tight linkage to the cystic fibrosis locus by in situ hybridization using fibroblasts with a 7q22 deletion. Hum Genet 1988 0.81
93 No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma. Hum Genet 1996 0.81
94 Close linkage of the Wilson's disease locus to D13S12 in the chromosomal region 13q21 and not to ESD in 13q14. Hum Genet 1990 0.81
95 Well-identifiable human chromosomes isolated from mitotic fibroblasts by a new method. Hum Genet 1982 0.81
96 Allelic gains and losses in distinct regions of chromosome 6 in gastric carcinoma. Cancer Genet Cytogenet 2001 0.80
97 Loss of heterozygosity for a chromosome 3 sequence presumably at 3p21 in small cell lung cancer. Cancer Genet Cytogenet 1987 0.80
98 A four-allele RFLP identified by an anonymous single copy genomic clone at 13q21-13qter [HGM8 assignment no. D13S12]. Nucleic Acids Res 1986 0.80
99 Comprehensive TP53-denaturing gradient gel electrophoresis mutation detection assay also applicable to archival paraffin-embedded tissue. Diagn Mol Pathol 1999 0.80
100 Different effects of 33258 Hoechst and DAPI in fluorescent staining of sister chromatids differentially substituted with bromodeoxyuridine. Histochemistry 1982 0.80
101 An anonymous single copy genomic clone at 13q12-13q13 identifies three RFLPs [HGM8 assignment no. D13S11]. Nucleic Acids Res 1986 0.80
102 Somatic mutations of the RET proto-oncogene are not required for tumor development in multiple endocrine neoplasia type 2 (MEN 2) gene carriers. Cancer Res 1996 0.80
103 Reduced endothelin-3 expression in sporadic Hirschsprung disease. Br J Surg 2000 0.80
104 Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10. Genomics 1989 0.80
105 Identification of crossovers in Wilson disease families as reference points for a genetic localization of the gene. Hum Genet 1992 0.79
106 Confirmation of clinical diagnosis in requests for prenatal prediction of SMA type I. J Neurol Neurosurg Psychiatry 1993 0.79
107 Identification of a novel mutation (867delA) in the glucose-6-phosphatase gene in two siblings with glycogen storage disease type Ia with different phenotypes. Hum Mutat 2000 0.79
108 Refinement by linkage analysis in two large families of the candidate region of the third locus (SCA3) for autosomal dominant cerebellar ataxia type I. Hum Genet 1995 0.79
109 A comparison of constitutive heterochromatin staining methods in two cases of familial heterochromatin deficiencies. Hum Genet 1979 0.79
110 A Hirschsprung disease locus at 22q11? J Med Genet 1999 0.79
111 BclI RFLP for the human vimentin gene. Nucleic Acids Res 1988 0.79
112 Chromosomal sublocalization of the 2;13 translocation breakpoint in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 1992 0.79
113 Frequency of the delta F508 mutation and XV2c,KM19 haplotypes in cystic fibrosis families from The Netherlands: haplotypes without delta F508 still in disequilibrium. Hum Genet 1990 0.78
114 Report of the sixth international workshop on human chromosome 3 mapping 1995. Cytogenet Cell Genet 1996 0.78
115 The clinical implications of a positive calcitonin test for C-cell hyperplasia in genetically unaffected members of an MEN2A kindred. Am J Hum Genet 1993 0.78
116 Ordering of polymorphic markers in the chromosome region 3p21. Cytogenet Cell Genet 1996 0.78
117 Tetrasomy 9p due to an intrachromosomal triplication of 9p13-p22. Am J Med Genet 1999 0.78
118 Isolation and regional localization of 25 anonymous DNA probes on a chromosome 13 hybrid panel. Cytogenet Cell Genet 1991 0.78
119 Localization of amplified c-myc and n-myc in small cell lung cancer cell lines. Cancer Genet Cytogenet 1989 0.78
120 Familial transmission of a translocation Y/14. Hum Genet 1979 0.78
121 Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet 1998 0.77
122 Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A. Hum Genet 1996 0.77
123 Qualitative and quantitative examination of rat and human fetal dopaminergic grafts. Stereotact Funct Neurosurg 1990 0.77
124 Assignment of the gene coding for human cytochrome c oxidase subunit VIb to chromosome 19, band q13.1, by fluorescence in situ hybridisation. Hum Genet 1991 0.77
125 Heterogeneity of human chromosome 9 constitutive heterochromatin as revealed by sequential distamycin A/DAPI staining and C-banding. Hum Genet 1981 0.77
126 Analysis of a metastasizing testicular mixed gonadal stromal tumor with osteosarcoma components suggests that a malignant tumor with the histology of osteosarcoma may develop without primary involvement of RB1 and TP53. Cancer Res 1992 0.77
127 A high frequency RFLP identified by an anonymous single copy genomic clone at 13q14.1-13q14.2 [HGM8 assignment no. D13S22]. Nucleic Acids Res 1987 0.77
128 Clinical definition of hereditary non-polyposis colorectal cancer: a search for the impossible? Scand J Gastroenterol Suppl 2001 0.77
129 Glycogen storage disease type Ia: four novel mutations (175delGG, R170X, G266V and V338F) identified. Mutations in brief no. 220. Online. Hum Mutat 1999 0.77
130 A nonsense mutation (Arg-196-Term) in exon 6 of the human TP53 gene identified in small cell lung carcinoma. Mol Cell Probes 1996 0.76
131 An integrated map of human chromosome 13 allowing regional localization of genetic markers. Eur J Hum Genet 1995 0.76
132 A PCR-aided transcript titration assay revealing very low expression of a gene at band 3p21 in 33 cells lines derived from all types of lung cancer. Eur J Hum Genet 1993 0.76
133 The Giemsa-11 technique for species-specific chromosome differentiation. A simple stain modification leading to dependable direct and sequential staining procedures. Histochemistry 1984 0.76
134 Implications of intragenic marker homozygosity and haplotype sharing in a rare autosomal recessive disorder: the example of the collagen type XVII (COL17A1) locus in generalised atrophic benign epidermolysis bullosa. Hum Genet 1997 0.76
135 Identification of a tumor marker chromosome by flow sorting, DNA amplification in vitro, and in situ hybridization of the amplified product. Genes Chromosomes Cancer 1993 0.75
136 The anonymous probe pG50 identifying the locus D13S24 detects a two allele RFLP with SspI. Nucleic Acids Res 1989 0.75
137 A new RFLP identified at the D3S48 locus. Nucleic Acids Res 1991 0.75
138 The single copy probe pG24E2.4 [D13S21] reveals a Bsp1286 RFLP at 13q14.1-q14.2. Nucleic Acids Res 1989 0.75
139 The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol. J Med Genet 1997 0.75
140 Remarks on the article "Use of Linkage Equilibrium Data in Prenatal Diagnosis of Cystic Fibrosis" by L. Strain et al. Hum Genet 1989 0.75
141 Stabilization of chromosomes by DNA intercalators for flow karyotyping and identification by banding of isolated chromosomes. Histochemistry 1987 0.75
142 Rapid identification of chromosomes carrying silver-stained nucleolus-organizing regions: application to case of 21/21 Robertsonian translocation. Hum Genet 1978 0.75
143 A sublocus of the multicopy microsatellite marker CMS1 maps proximal to spinal muscular atrophy (SMA) as shown by recombinant analysis. Hum Genet 1995 0.75
144 Localization by in situ hybridization of three 3p probes with respect to the breakpoint in a t(3;8) in hereditary renal cell carcinoma. Cancer Genet Cytogenet 1991 0.75
145 Genome analysis of small cell lung cancer (SCLC) and clinical significance. Eur J Respir Dis Suppl 1987 0.75
146 Construction of a pulsed-field map around D3S3 using partially demethylated DNA. Cytogenet Cell Genet 1995 0.75
147 An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy. Cancer Immunol Immunother 1999 0.75
148 Genetics as a diagnostic tool in sarcomatoid renal-cell cancer. Int J Cancer 1997 0.75
149 Coexistent Hirschsprung's disease and esophageal achalasia in male siblings. J Pediatr Surg 1997 0.75
150 Defining the position of the breakpoint of the constitutional t(3;6) occurring in a family with renal cell carcinoma. Genes Chromosomes Cancer 1995 0.75
151 A comparison of the effect of 5-bromodeoxyuridine substitution on 33258 Hoechst- and DAPI-fluorescence of isolated chromosomes by bivariate flow karyotyping. Histochemistry 1986 0.75
152 The role of chromosomal proteins in the induction of a differential staining of sister chromatids by light. Histochem J 1981 0.75
153 Amplification and expression of different myc-family genes in a tumor specimen and 3 cell lines derived from one small-cell lung cancer patient during longitudinal follow-up. Int J Cancer 1989 0.75
154 Rapid irradiation procedure for obtaining permanent differential staining of sister chromatids and aspects of its underlying mechanism. Hum Genet 1981 0.75
155 Utility of fragmented human fetal tissue as a potential dopaminergic brain graft in Parkinson's disease. Stereotact Funct Neurosurg 1993 0.75
156 Breakpoint mapping by FISH in a Sotos patient with a constitutional translocation t(3;6) J Med Genet 1999 0.75
157 Effectiveness of prevention of cystic fibrosis by artificial insemination by donor can be markedly improved by DNA-analysis of sperm donors. Am J Med Genet 1989 0.75
158 A highly informative dinucleotide repeat polymorphism at D13S201, between RB1 and WND. Hum Genet 1995 0.75
159 A deletion hybrid breakpoint map of the chromosomal region 13q14-q21 orders 19 genetic markers in 10 intervals. Eur J Hum Genet 1994 0.75
160 A novel mutation (G1249R) in exon 20 of the CFTR gene. Hum Mutat 1994 0.75
161 The EUROGEM map of human chromosome 13. Eur J Hum Genet 1994 0.75
162 Involvement of sulfhydryl groups of chromosomal proteins in sister chromatid differentiation. Chromosoma 1980 0.75
163 A human glioblastoma line with karyotypic nullisomy 13 containing several chromosome 13-specific sequences. Cancer Genet Cytogenet 1988 0.75
164 Identification of key recombinants in multiplex SMA families. Genomics 1994 0.75
165 Inclusion of new microsatellite repeats in allelic loss analysis excludes retention of heterozygosity in the renal cell carcinoma critical region in 3p21. Cancer Genet Cytogenet 2000 0.75
166 Age-dependent variability of ribosomal RNA-gene activity in man as determined from frequencies of silver staining nucleolus organizing regions on metaphase chromosomes of lymphocytes and fibroblasts. Mech Ageing Dev 1979 0.75
167 Absence of mutations in the RET gene in acute myeloid leukemia. Ann Hematol 1997 0.75
168 The mechanism of differential sister chromatid fluorescence as studied with the GC-specific DNA-ligand mithramycin. Exp Cell Res 1980 0.75
169 Effects on chromosomal proteins in sister chromatid differentiation by incorporation of 5-bromodeoxyuridine into DNA. Exp Cell Res 1982 0.75
170 [DNA studies in proximal spinal muscular atrophy]. Ned Tijdschr Geneeskd 1991 0.75
171 Ordering of markers in the pericentromeric region of chromosome 10. Hum Genet 1995 0.75
172 Banding of unfixed mitotic chromosomes in suspension after release from human lymphocytes and fibroblasts. Hum Genet 1984 0.75
173 Proteolytic capacities of cystic fibrosis and control fibroblasts towards Tamm-Horsfall glycoprotein. Clin Chim Acta 1984 0.75
174 Isolated metaphase chromosomes stabilized by DNA-intercalation or polyamine addition: a comparison. Cell Biol Int Rep 1984 0.75